Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Xstrahl Spotlights Full Range of X Ray Therapy and Radiation Research Systems at ESTRO 2019

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Penumbra Wins CE Mark for Thunderbolt...

Penumbra announced that it has secured CE mark approval...

Kaopiz Holdings, QuantumTX Partner on AI...

In a significant move toward transforming the healthcare sector,...

New InterSystems TrakCare Community Solution Goes...

Leading community health service codesigns Australian solution to improve...

Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its full range of superficial/orthovoltage treatments systems and radiation research platforms at ESTRO 2019.

โ€œWe look forward to seeing many of our colleagues, customers and channel partners at this yearโ€™s premier European radiotherapy meeting,โ€ says Adrian Treverton, chief executive officer. โ€œItโ€™s an exciting time at Xstrahl and we have some significant new product advances to talk about, so visit the Xstrahl booth to learn more about the worldโ€™s most advanced superficial and radiation research systems.โ€

The new Xstrahl 150 device will be the companyโ€™s most comprehensive superficial system dedicated to skin cancer treatments, offering clinicians the ability to treat the full range of non-melanoma skin cancer cases with optimum dose control. It includes several features that enhance the capabilities of Xstrahlโ€™s current 150kV superficial system, including built-in dosimetry control, filter and applicator recognition and suitability for use with oval applicators.

Other products in Xstrahlโ€™s market-leading range of superficial and orthovoltage treatment systems โ€“ from the RADiant 80kV treatment system for dermatological applications to the powerful Xstrahl 300kV system for treating non-melanoma skin cancer, benign and palliative conditions โ€“ will also be spotlighted at the event.

Xstrahlโ€™s family of treatment planning and information management software products will also be on show, including DICOM and HL7-based connectivity options to third party oncology information databases such as ARIA and Mosaiq.

The Small Animal Radiation Research Platform (SARRP), is the most advanced commercially available 3D image guided micro irradiator and serves as the flagship system manufactured by Xstrahl. Through state-of-the-art image acquisition, reconstruction, and treatment planning, SARRP serves as a dynamic research tool for preclinical radiobiology research. The results of research carried out on SARRP systems in Oxford (UK), Dijon (France) and Munich (Germany) features in some of the key papers being presented at this yearโ€™s ESTRO show.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Penumbra Wins CE Mark for Thunderbolt Thrombectomy System

Penumbra announced that it has secured CE mark approval...

Kaopiz Holdings, QuantumTX Partner on AI Healthcare Solution

In a significant move toward transforming the healthcare sector,...

New InterSystems TrakCare Community Solution Goes Live at Gateway Health

Leading community health service codesigns Australian solution to improve...

ResMed Completes $340 Million Acquisition of Noctrix Health

Global sleep and breathing health company ResMed has finalized...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป